PAP
XERS icon

Persistent Asset Partners’s Xeris Biopharma Holdings XERS Stock Holding History

Persistent Asset Partners’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Hold
35,661
– – 0.08% 165
2026
Q1 		$207K Sell
35,661
-9,948
-22% -$66K 0.08% 191
2025
Q4 		$358K Buy
45,609
+28,407
+165% +$224K 0.16% 165
2025
Q3 		$140K Buy
+17,202
New +$114K 0.1% 147

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Persistent Asset Partners's XERS Position: Q2 2026 in Review

Persistent Asset Partners held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 35,661 shares worth $282K. The position accounts for 0.08% of the portfolio, ranked #165.

Persistent Asset Partners first reported a position in XERS in Q3 2025 and has held it in 4 quarters since. The position peaked at $358K in Q4 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Persistent Asset Partners held 35,661 shares of Xeris Biopharma Holdings worth $282K as of Q2 2026.
  • Persistent Asset Partners left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up 0.08% of Persistent Asset Partners's portfolio in Q2 2026, its #165 holding.
  • Persistent Asset Partners first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
  • Persistent Asset Partners's Xeris Biopharma Holdings position peaked at $358K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.